
Know about weight-loss drug Mounjaro, released by Eli Lilly in India
Mounjaro (tirzepatide) is a weekly-administered injection for obesity and Type-2 diabetes. It received approval from India’s Central Drugs Standard Control Organisation (CDSCO), and was released on Thursday (March 20). A 2.5 mg vial of Mounjaro is priced …